Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

Author： Visco Carlo   Cortelezzi Agostino   Moretta Francesca   Falisi Erika   Maura Francesco   Finotto Silvia   Barcellini Wilma   Ambrosetti Achille   Neri Antonino   Ruggeri Marco   Rodeghiero Francesco  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1261-1265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The ABC of chronic lymphocytic leukemia: Etiology of cytopenias is important in staging and management

By Barr Paul M.   Zent Clive S.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1219-1220

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Liu Nina   O’Brien Susan  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 297-304

Humana Press, Inc

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options

By Wierda William G.   Keating Michael J.   O'Brien Susan  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 163-178

Adis International

Access to resources Recommend Favorite

New and Repositioning Approaches to the Treatment of Chronic Lymphocytic Leukemia(

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 67-100

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 666-682

Bentham Science Publishers

Access to resources Recommend Favorite